Conference
1201 Respiratory Syncytial Virus Prophylaxis in Special Populations
Abstract
Objective: To determine palivizumab utilization in infants with pre-existing disease within the Canadian Registry Database (CARESS).Methods: A prospective registry of infants from 27 sites who received palivizumab during the 2006-2009 RSV seasons. Demographic data were collected from the parent/caregiver at enrollment. Data on palivizumab utilization, compliance, and outcomes related to respiratory infection (RI) events were collected monthly. …
Authors
Paes B; Li A; Lanctot K; Mitchell I
Volume
68
Pagination
pp. 594-594
Publisher
Springer Nature
Publication Date
November 2010
DOI
10.1203/00006450-201011001-01201
Conference proceedings
Pediatric Research
Issue
Suppl 1
ISSN
0031-3998